Corrigendum to "Inhibition of MRP4 alleviates sepsis-induced acute lung injury in rats" [Int. Immunopharmacol. 72 (2019) 211-217].

作者信息

Xia Wenfang, Zhang Huanming, Pan Zhou, Li Guang, Zhou Qingshan, Hu Dan, Liu Yu

机构信息

Department of Critical Care Medicine, Renmin Hospital of Wuhan University, Wuhan 430060, China.

Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan 430060, China; Cardiovascular Research Institute, Wuhan University, Wuhan 430060, China.

出版信息

Int Immunopharmacol. 2023 Sep;122:110699. doi: 10.1016/j.intimp.2023.110699. Epub 2023 Jul 26.

DOI:10.1016/j.intimp.2023.110699

PMID:37500384

Abstract

摘要

相似文献

Corrigendum to "Inhibition of MRP4 alleviates sepsis-induced acute lung injury in rats" [Int. Immunopharmacol. 72 (2019) 211-217].

Int Immunopharmacol. 2023 Sep;122:110699. doi: 10.1016/j.intimp.2023.110699. Epub 2023 Jul 26.

Inhibition of MRP4 alleviates sepsis-induced acute lung injury in rats.MRP4 抑制减轻大鼠脓毒症诱导的急性肺损伤。

Int Immunopharmacol. 2019 Jul;72:211-217. doi: 10.1016/j.intimp.2019.04.009. Epub 2019 Apr 14.

Corrigendum to "(E)-2-methoxy-4-(3-(4-methoxyphenyl)prop-1-en-1-yl)phenol alleviates inflammatory responses in LPS-induced mice liver sepsis through inhibition of STAT3 phosphorylation" [Int. Immunopharmacol. 125(Part B) (2023) 111124].对“(E)-2-甲氧基-4-(3-(4-甲氧基苯基)丙-1-烯-1-基)苯酚通过抑制STAT3磷酸化减轻脂多糖诱导的小鼠肝脏脓毒症中的炎症反应”的勘误[《国际免疫药理学》125(Part B)(2023)111124]

Int Immunopharmacol. 2024 Aug 20;137:112543. doi: 10.1016/j.intimp.2024.112543. Epub 2024 Jun 25.

Corrigendum to "MEGF6 prevents sepsis-induced acute lung injury in mice" [Int. Immunopharmacol. 123 (2023) 110727].

Int Immunopharmacol. 2024 May 30;133:111787. doi: 10.1016/j.intimp.2024.111787. Epub 2024 Apr 18.

Corrigendum to "Exosomal miR-127-5p from BMSCs alleviated sepsis-related acute lung injury by inhibiting neutrophil extracellular trap formation" [Int. Immunopharmacol. 123 (2023) 110759].《骨髓间充质干细胞来源的外泌体miR-127-5p通过抑制中性粒细胞胞外陷阱形成减轻脓毒症相关急性肺损伤》的勘误[《国际免疫药理学》123卷（2023年）110759页]

Int Immunopharmacol. 2023 Dec;125(Pt A):111076. doi: 10.1016/j.intimp.2023.111076. Epub 2023 Oct 20.

MiR-490 alleviates sepsis-induced acute lung injury by targeting MRP4 in new-born mice.miR-490 通过靶向新生小鼠的 MRP4 缓解脓毒症诱导的急性肺损伤。

Acta Biochim Pol. 2021 Mar 22;68(2):151-158. doi: 10.18388/abp.2020_5397.

Corrigendum to "Liproxstatin-1 alleviates LPS/IL-13-induced bronchial epithelial cell injury and neutrophilic asthma in mice by inhibiting ferroptosis" [Int. Immunopharmacol. 109 (2022) 108770].《Liproxstatin-1通过抑制铁死亡减轻LPS/IL-13诱导的小鼠支气管上皮细胞损伤和嗜中性粒细胞性哮喘》的勘误[《国际免疫药理学》109卷（2022年）108770页]

Int Immunopharmacol. 2023 Feb;115:109482. doi: 10.1016/j.intimp.2022.109482. Epub 2023 Jan 6.

Corrigendum to "Molsidomine alleviates acetic acid-induced colitis in rats by reducing oxidative stress, inflammation and apoptosis" [Int. Immunopharmacol. 99 (2021) 108005].《硝普钠通过减轻氧化应激、炎症和细胞凋亡缓解乙酸诱导的大鼠结肠炎》的勘误 [《国际免疫药理学》99卷（2021年）108005页]

Int Immunopharmacol. 2022 Apr;105:108575. doi: 10.1016/j.intimp.2022.108575. Epub 2022 Feb 1.

Corrigendum to "Neutrophil elastase in dexmedetomidine alleviating sepsis-related renal injury in rats" [Int. Immunopharmacol. 122 (2023) 110441].《右美托咪定中的中性粒细胞弹性蛋白酶减轻大鼠脓毒症相关肾损伤》的勘误 [《国际免疫药理学》122 (2023) 110441]

Int Immunopharmacol. 2024 Feb 15;128:111577. doi: 10.1016/j.intimp.2024.111577. Epub 2024 Jan 28.

Corrigendum to "Pmepa1 knockdown alleviates SpA-induced pyroptosis and osteogenic differentiation inhibition of hBMSCs via p38MAPK/NLRP3 axis" [Int. Immunopharmacol. 124(Part A) (2023) 110843].《“Pmepa1基因敲低通过p38丝裂原活化蛋白激酶/核苷酸结合寡聚化结构域样受体蛋白3轴减轻脊柱关节炎诱导的人骨髓间充质干细胞焦亡和成骨分化抑制”的勘误》[《国际免疫药理学》124(Part A)(2023)110843]

Int Immunopharmacol. 2023 Nov;124(Pt A):111013. doi: 10.1016/j.intimp.2023.111013. Epub 2023 Oct 6.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验